Surface passivation dependent photoluminescence from silicon quantum dot phosphors

Biodistributions and Imaging of Poly(ethylene glycol)-Conjugated Silicon Quantum Dot Nanoparticles in Osteosarcoma Models via Intravenous and Intratumoral Injections

Osteosarcoma is a malignant tumor with relatively high mortality rates in children and adolescents. While nanoparticles have been widely used in assisting the diagnosis and treatment of cancers, the biodistributions of nanoparticles in osteosarcoma models have not been well studied. Herein, we synthesize biocompatible and highly photoluminescent silicon quantum dot nanoparticles (SiQDNPs) and investigate their biodistributions in osteosarcoma mouse models after intravenous and intratumoral injections by fluorescence imaging. The bovine serum albumin (BSA)-coated and poly(ethylene glycol) (PEG)-conjugated SiQDNPs, when dispersed in phosphate-buffered saline (PBS), can emit red photoluminescence with the photoluminescence quantum yield more than 30% and have very low in vitro and in vivo toxicity. The biodistributions after intravenous injections reveal that the SiQDNPs are mainly metabolized through the livers in mice, while only slight accumulation in the osteosarcoma tumor is observed. Furthermore, the PEG conjugation can effectively extend the circulation time. Finally, a mixture of SiQDNPs and indocyanine green (ICG), which complement each other in the spectral range and diffusion length, is directly injected into the tumor for imaging. After the injection, the SiQDNPs with relatively large particle sizes stay around the injection site, while the ICG molecules diffuse over a broad range, especially in the muscular tissue. By taking advantage of this property, the difference between the osteosarcoma tumor and normal muscular tissue is demonstrated.

Solvent-Type Passivation Strategy Controls Solid-State Self-Quenching-Resistant Behavior in Sulfur Dots

Treatment of sulfur dots with polyethylene glycol (PEG) has been an efficient way to achieve a high luminescence quantum yield, and such a PEG-related quantum dot (QD)-synthesis strategy has been well documented. However, the polymeric insulating capping layer acting as the "thick shell" will significantly slow down the electron-transfer efficiency and severely hamper its practical application in an optoelectric field. Especially, the employment of synthetic polymers with long alkyl chains or large molecular weights may lead to structural complexity or even unexpected changes of physical characteristics for QDs. Therefore, in sulfur dot preparation, it is a breakthrough to use short-chain molecular species to replace PEG for better control and reproducibility. In this article, a solvent-type passivation (STP) strategy has been reported, and no PEG or any other capping agent is required. The main role of the solvent, ethanol, is to directly react with NaOH, and the generated sodium ethoxide passivates the surface defects. The afforded STP-enhanced emission sulfur dots (STPEE-SDs) possess not only the self-quenching-resistant feature in the solid state but also the extension of fluorescence band toward the wavelength as long as 645 nm. The realization of sulfur dot emission in the deep-red region with a decent yield (8.7%) has never been reported. Moreover, a super large Stokes shift (300 nm, λ_ex = 345 nm, λ_em = 645 nm) and a much longer decay lifetime (109 μs) have been found, and such values can facilitate to suppress the negative influence from background signals. Density functional theory demonstrates that the surface passivation via sodium ethoxide is dynamically favorable, and the spectroscopic insights into emission behavior could be derived from the passivation effect of the sulfur vacancy as well as the charge-transfer process dominated by the highly electronegative ethoxide layer.

Broadband near-infrared light source derived from Cr3+-doped phosphors and a blue LED chip

NIR-emitting YAl₃(BO₃)₄:Cr³⁺/Yb³⁺ (YAB:Cr/Yb) and NaScSi₂O₆:Cr³⁺ (BSSO:Cr) phosphors were demonstrated as luminescent converters for broadband NIR phosphor-converted LEDs (pc-LEDs). YAB:Cr/Yb phosphors show emissions in 670-800 nm (Cr³⁺ emission) and 950-1050 nm (Yb³⁺ emission) upon excitation at 450 nm. In the BSSO host, Cr³⁺ ions occupy Sc³⁺ sites with relatively weak crystal field, and thus a broadband Cr³⁺ emission at longer wavelengths of 750-950 nm is found for BSSO:Cr phosphors. Moreover, temperature-dependent spectral studies indicate that both YAB:Cr/Yb and BSSO:Cr phosphors exhibit good thermal stability, and more than 80% of the initial emission intensities can be sustained at 150°C. A NIR pc-LED prototype was fabricated by integrating these two phosphors with a blue LED chip (∼450  nm), which generated a broadband emission in the NIR spectral range from 780 to 1050 nm. A NIR light output power of ∼26  mW was achieved at the injection current of 100 mA, with the corresponding energy conversion efficiency of ∼8.6%.

Silicon Quantum Dot Nanoparticles with Antifouling Coatings for Immunostaining on Live Cancer Cells

Fluorescent silicon quantum dots (SiQDs) have shown a great potential as antiphotobleaching, nontoxic and biodegradable labels for various in vitro and in vivo applications. However, fabricating SiQDs with high water-solubility and high photoluminescence quantum yield (PLQY) remains a challenge. Furthermore, for targeted imaging, their surface chemistry has to be capable of conjugating to antibodies, as well as sufficiently antifouling. Herein, antibody-conjugated SiQD nanoparticles (SiQD-NPs) with antifouling coatings composed of bovine serum albumin (BSA) and polyethylene glycol (PEG) are demonstrated for immunostaining on live cancer cells. The monodisperse SiQD-NPs of diameter about 130 nm are synthesized by a novel top-down method, including electrochemical etching, photochemical hydrosilylation, high energy ball milling, and "selective-etching" in HNO3 and HF. Subsequently, the BSA and PEG are covalently grafted on to the SiQD-NP surface through presynthesized chemical linkers, resulting in a stable, hydrophilic, and antifouling organic capping layer with isothiocyanates as the terminal functional groups for facile conjugation to the antibodies. The in vitro cell viability assay reveals that the BSA-coated SiQD-NPs had exceptional biocompatibility, with minimal cytotoxicity at concentration up to 1600 μg mL(-1). Under 365 nm excitation, the SiQD-NP colloid emits bright reddish photoluminescence with PLQY = 45-55% in organic solvent and 5-10% in aqueous buffer. Finally, through confocal fluorescent imaging and flow cytometry analysis, the anti-HER2 conjugated SiQD-NPs show obvious specific binding to the HER2-overexpressing SKOV3 cells and negligible nonspecific binding to the HER2-nonexpressing CHO cells. Under similar experimental conditions, the immunofluorescence results obtained with the SiQD-NPs are comparable to those using conventional fluorescein isothiocyanate (FITC).

Development of a Fe3O4@SnO2:Er3+,Yb3+–APTES nanocarrier for microwave-triggered controllable drug release, and the study of the loading and release mechanisms using microcalorimetry

New multifunctional core–shell nanocomposites were synthesized and applied as an efficient microwave sensitive nanocarrier for on-command drug release.